Markets

Agilent Technologies Receives EU Certification For Code SK006 As Companion Diagnostic To Aid In Identifying Patients With Epithelial Ovarian, Fallopian Tube, Or Primary Peritoneal Carcinoma

Jul 23, 2026 · 08:04 AM ET· updated 2h ago

Agilent Technologies Inc. (NYSE:A) today announced it has received European Union (EU) certification for PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic indicated to aid in identifying patients with

Why It Matters

Agilent got official permission from Europe to sell a medical test that helps doctors find certain cancer patients who might benefit from specific treatments. This shows the company's cancer-testing business is growing and trusted by regulators.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

A138.41

+4.95 (+3.71%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.